ISSN: 2329-8790
+44 1478 350008
Farid Menaa
Department of Nanomedicine,Oncology and Stem Cells Fluorotronics, Inc San Diego
California, USA
Dr. Farid Menaa is an renowned multidisciplinar professional with expertise in biology, medicine, chemistry and nanomedicine. He was the R&D head of Fluorotronics, Inc., CA, USA, a premier company in fluorine chemistry and nanotechnology. He co-pioneered the Spectro-Fluor technology, aso known as Carbone-Fluorine Spectroscopy, for biomedical and pharmaceutical applications. Besides, Dr. Menaa assumed different academic and industrial functions in various countries and prestigious organizations. One of his recent research project in hematology highlight new rare genomic variants involved in the susceptibility of stroke in adult patients with sickle cell anemia. Dr. Menaa is member of several prestigious scientific and medical societies. He serves the community as editor and reviewer for many esteemed journals. Dr. Menaa also organizes scientific events and is an international consulting expert in integrative, regenerative, personalized and translational green medicine. Dr. Menaa earned several awards for his achievements and holds dozen of articles, often as first author and/or as project coordinator. Dr. Menaa cooperates with various organizations worldwide to implement more efficient and safer theranostic options.
Fluorotonics